CMG Pharmaceutical Co. Ltd Cash Flow Quality Index
CMG Pharmaceutical Co. Ltd cash flow quality index. CMG Pharmaceutical Co. Ltd (058820) has a Cash Flow Quality Index of -0.71x as of September 2025. Operating cash flow of ₩-4.04 Billion is below net income of ₩5.73 Billion, suggesting accrual-heavy earnings not yet converted to cash. See CMG Pharmaceutical Co. Ltd (058820) flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of CMG Pharmaceutical Co. Ltd (2014–2024)
Cash flow quality index of CMG Pharmaceutical Co. Ltd from 2014 to 2024. Historical Cash Flow Quality Index for CMG Pharmaceutical Co. Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore 058820 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
CMG Pharmaceutical Co. Ltd Cash Flow Quality Index by Year (2014–2024)
CMG Pharmaceutical Co. Ltd cash flow quality index by year from 2014 to 2024. Year-by-year earnings quality comparison for CMG Pharmaceutical Co. Ltd. For the full cash flow conversion analysis, see 058820 cash flow conversion.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.11x | ₩290.09 Million | ₩2.69 Billion | ▼ -82.2% |
| 2023 | 0.61x | ₩3.91 Billion | ₩6.46 Billion | ▼ -65.9% |
| 2021 | 1.78x | ₩5.63 Billion | ₩3.17 Billion | ▼ -87.0% |
| 2020 | 13.69x | ₩2.94 Billion | ₩215.00 Million | ▲ +1379.9% |
| 2019 | 0.93x | ₩2.82 Billion | ₩3.05 Billion | ▲ +532.9% |
| 2018 | 0.15x | ₩886.78 Million | ₩6.07 Billion | ▼ -78.7% |
| 2017 | 0.69x | ₩1.95 Billion | ₩2.83 Billion | ▼ -48.6% |
| 2016 | 1.34x | ₩2.31 Billion | ₩1.73 Billion | ▼ -70.9% |
| 2014 | 4.59x | ₩724.89 Million | ₩158.04 Million | — |